Tuberculosis Vaccines and Therapeutics

The WHO estimates that the largest number of new tuberculosis (TB) cases in 2008 occurred in the South-East Asia Region, which accounted for 34% of incident cases globally. However, the estimated inci...

Alternative Medicine - news, reports, trials and publications

Traditional Chinese Medicine (simplified Chinese: 中医; traditional Chinese: 中醫; pinyin: zhōng yī: "Chinese Medicine") refers to a broad range of medicine practices sharing common...

SERAPHIN study

SERAPHIN - STUDY WITH ENDOTHELIN RECEPTOR ANTAGONIST IN PULMONARY ARTERIAL HYPERTENSION TO IMPROVE CLINICAL OUTCOME. SERAPHIN (Study with an Endothelin Rece...

Prostate Cancer Pub Med

Prostate cancer is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostate ca...

Yellow Fever

Yellow fever is an acute viral hemorrhagic disease. The virus is a 40 to 50 nm enveloped RNA virus with positive sense of the Flaviviridae family. The yellow fever virus is transmitted by the bite o...

Stronger Exelon Patch Wins FDA Nod

(MedPage Today) -- A transdermal patch delivering rivastigmine (Exelon) at a 40% higher rate than the previous maximum strength has been cleared by the FDA for patients with mild to moderate Alzheimer...

FDA Approves Higher Dose of Exelon Patch

The FDA has approved a higher dose of Exelon Patch (rivastigmine transdermal system) for the treatment of people with mild to moderate Alzheimer's disease.

FDA approves Novartis’ Exelon Patch to treat mild to moderate AD

The US Food and Drug Administration has approved a higher dose of Exelon Patch (rivastigmine transdermal system) for the treatment of people with mild to moderate Alzheimer's disease.

Novartis wins FDA approval for new dosage strength of Exelon Patch

Novartis has obtained the US Food and Drug Administration (FDA) approval for a new 13.3 mg/24 h dosage strength of its Exelon Patch (rivastigmine transdermal system), designed to treat patients with m...

US FDA approves higher dose of Novartis Exelon Patch

The US FDA has approved a higher, 13.3 mg dose of Novartis' Exelon Patch (rivastigmine transdermal system) for treating patients with mild to moderate Alzheimer's disease. The new, 13.3mg/24 h patch...

FDA backs higher dose of Novartis Exelon Patch for Alzheimer's

The US Food and Drug Administration has approved a higher dose of Swiss drug major Novartis' (NOVN: VX) Exelon Patch (rivastigmine transdermal system) for the treatment of people with mild to moderate...

Exelon to sell Maryland power plants to Raven Power for $400 mln

Aug 9 (Reuters) - Exelon Corp said it will sell its three coal-fired power plants in Maryland to Raven Power Holdings for $400 million to fulfill the conditions for its merger with Constellation Energ...

Higher Dose of Novartis Drug Exelon Patch Approved By FDA for Patients With Mild to Moderate Alzheimer's Disease

EAST HANOVER, N.J., Sept. 4, 2012 /PRNewswire/ -- The US Food and Drug Administration has approved a higher dose of Exelon Patch (rivastigmine transdermal system) for the treatment of people with mild...

Sexual medicine disparities between Asia and North America: commentary on male sexual dysfunction in Asia.

Southeast Asian Foot-and-Mouth Disease Viruses in Eastern Asia.

Foot-and-mouth disease (FMD) outbreaks recently affected 2 countries (Japan and South Korea) in eastern Asia that were free of FMD without vaccination. Analysis of viral protein 1 nucleotide sequences...

Iron Storage Disease in Asia-Pacific Populations: the Importance of Non-HFE Mutations.

Hereditary hemochromatosis (HH) is a widely recognized and well-studied condition in European populations. This is largely due to the high prevalence of the C282Y mutation of HFE. Although less common...

Erratum to: QTL for yield and associated traits in the Seri/Babax population grown across several environments in Mexico, in the West Asia, North Africa, and South Asia regions.

Endemic fungal infections in the Asia-Pacific region.

Endemic mycoses are important fungal infections in their respective habitats. In the Asia-Pacific region, an accurate epidemiological picture of endemic mycoses is elusive; few epidemiological surveys...